News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Finley John David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 397 shares
@ $0.5501, valued at
$218.4
Exercised 1,309 options to buy
@ $0 |
|
| 09/29/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 15,000 shares
@ $0.5392, valued at
$8.1k
|
|
| 08/14/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 1,040 shares
@ $0.7, valued at
$728
Exercised 3,475 options to buy
@ $0 |
|
| 07/06/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 389 shares
@ $1.764, valued at
$686.2
Exercised 1,309 options to buy
@ $0 |
|
| 04/05/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Paid exercise price by delivering 435 shares
@ $2.01, valued at
$874.4
Exercised 1,309 options to buy
@ $0 |
|
| 02/08/2023 |
4
| Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 41,700 options to buy
@ $0
Granted 32,500 options to buy
@ $0
Granted 57,200 options to buy
@ $2.4, valued at
$137.3k
|
|
| 01/06/2023 |
4
| Finley John David (CEO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 5,236 options to buy
@ $0 |
|
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Acquired 12,545 shares
@ $0 |
|
| 03/25/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Bought 7,500 shares
@ $1.0899, valued at
$8.2k
|
|
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 178,091 options to buy
@ $2.32, valued at
$413.2k
|
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|